Clinical trials
Phase 3 Mumps trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
38 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 3 |
| 2006 | 5 |
| 2007 | 4 |
| 2008 | 3 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 5 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 34 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 14 |
| Merck Sharp & Dohme LLC | 14 |
| Sanofi Pasteur, a Sanofi Company | 4 |
| Novartis Vaccines | 1 |
| Shanghai Institute Of Biological Products | 1 |
| Sinovac (Dalian) Vaccine Technology Co., Ltd. | 1 |
| Sinovac Research and Development Co., Ltd. | 1 |
| The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) | 1 |
| University of Zurich | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mumps | 38 |
| Measles | 36 |
| Rubella | 35 |
| Chickenpox | 28 |
| Haemophilus Infections | 4 |
| Meningitis, Meningococcal | 3 |
| Diphtheria | 1 |
| Encephalitis, Japanese | 1 |
| Hepatitis B | 1 |
| Meningitis | 1 |
Trials
Showing 51 to 38 of 38. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.